REPORT ID 13310

United States Chickenpox Vaccine Market Report 2017

Publish Date
21-Nov-17
Pages
99
Format
Electronic (PDF)

In this report, the United States Chickenpox Vaccine market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:
    The West
    Southwest
    The Middle Atlantic
    New England
    The South
    The Midwest
with sales (volume), revenue (value), market share and growth rate of Chickenpox Vaccine in these regions, from 2012 to 2022 (forecast).

United States Chickenpox Vaccine market competition by top manufacturers/players, with Chickenpox Vaccine sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
    Merck & Co.
    Sanofi Pasteur
    GSK
    Shanghai Institute
    BCHT
    Changsheng
    Keygen
    Green Cross
    Biken

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    Monovalent Vaccine
    Combination Vaccine
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Kids Injection
    Adults Injection

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

United States Chickenpox Vaccine Market Report 2017
1 Chickenpox Vaccine Overview
    1.1 Product Overview and Scope of Chickenpox Vaccine
    1.2 Classification of Chickenpox Vaccine by Product Category
        1.2.1 United States Chickenpox Vaccine Market Size (Sales Volume) Comparison by Type (2012-2022)
        1.2.2 United States Chickenpox Vaccine Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
        1.2.3 Monovalent Vaccine
        1.2.4 Combination Vaccine
    1.3 United States Chickenpox Vaccine Market by Application/End Users
        1.3.1 United States Chickenpox Vaccine Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
        1.3.2 Kids Injection
        1.3.3 Adults Injection
    1.4 United States Chickenpox Vaccine Market by Region
        1.4.1 United States Chickenpox Vaccine Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 The West Chickenpox Vaccine Status and Prospect (2012-2022)
        1.4.3 Southwest Chickenpox Vaccine Status and Prospect (2012-2022)
        1.4.4 The Middle Atlantic Chickenpox Vaccine Status and Prospect (2012-2022)
        1.4.5 New England Chickenpox Vaccine Status and Prospect (2012-2022)
        1.4.6 The South Chickenpox Vaccine Status and Prospect (2012-2022)
        1.4.7 The Midwest Chickenpox Vaccine Status and Prospect (2012-2022)
    1.5 United States Market Size (Value and Volume) of Chickenpox Vaccine (2012-2022)
        1.5.1 United States Chickenpox Vaccine Sales and Growth Rate (2012-2022)
        1.5.2 United States Chickenpox Vaccine Revenue and Growth Rate (2012-2022)

2 United States Chickenpox Vaccine Market Competition by Players/Suppliers
    2.1 United States Chickenpox Vaccine Sales and Market Share of Key Players/Suppliers (2012-2017)
    2.2 United States Chickenpox Vaccine Revenue and Share by Players/Suppliers (2012-2017)
    2.3 United States Chickenpox Vaccine Average Price by Players/Suppliers (2012-2017)
    2.4 United States Chickenpox Vaccine Market Competitive Situation and Trends
        2.4.1 United States Chickenpox Vaccine Market Concentration Rate
        2.4.2 United States Chickenpox Vaccine Market Share of Top 3 and Top 5 Players/Suppliers
        2.4.3 Mergers & Acquisitions, Expansion in United States Market
    2.5 United States Players/Suppliers Chickenpox Vaccine Manufacturing Base Distribution, Sales Area, Product Type

3 United States Chickenpox Vaccine Sales (Volume) and Revenue (Value) by Region (2012-2017)
    3.1 United States Chickenpox Vaccine Sales and Market Share by Region (2012-2017)
    3.2 United States Chickenpox Vaccine Revenue and Market Share by Region (2012-2017)
    3.3 United States Chickenpox Vaccine Price by Region (2012-2017)

4 United States Chickenpox Vaccine Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)
    4.1 United States Chickenpox Vaccine Sales and Market Share by Type (Product Category) (2012-2017)
    4.2 United States Chickenpox Vaccine Revenue and Market Share by Type (2012-2017)
    4.3 United States Chickenpox Vaccine Price by Type (2012-2017)
    4.4 United States Chickenpox Vaccine Sales Growth Rate by Type (2012-2017)

5 United States Chickenpox Vaccine Sales (Volume) by Application (2012-2017)
    5.1 United States Chickenpox Vaccine Sales and Market Share by Application (2012-2017)
    5.2 United States Chickenpox Vaccine Sales Growth Rate by Application (2012-2017)
    5.3 Market Drivers and Opportunities

6  United States Chickenpox Vaccine Players/Suppliers Profiles and Sales Data
    6.1 Merck & Co.
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Chickenpox Vaccine Product Category, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 Merck & Co. Chickenpox Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
        6.1.4 Main Business/Business Overview
    6.2 Sanofi Pasteur
        6.2.2 Chickenpox Vaccine Product Category, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 Sanofi Pasteur Chickenpox Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
        6.2.4 Main Business/Business Overview
    6.3 GSK
        6.3.2 Chickenpox Vaccine Product Category, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 GSK Chickenpox Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
        6.3.4 Main Business/Business Overview
    6.4 Shanghai Institute
        6.4.2 Chickenpox Vaccine Product Category, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 Shanghai Institute Chickenpox Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
        6.4.4 Main Business/Business Overview
    6.5 BCHT
        6.5.2 Chickenpox Vaccine Product Category, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 BCHT Chickenpox Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
        6.5.4 Main Business/Business Overview
    6.6 Changsheng
        6.6.2 Chickenpox Vaccine Product Category, Application and Specification
            6.6.2.1 Product A
            6.6.2.2 Product B
        6.6.3 Changsheng Chickenpox Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
        6.6.4 Main Business/Business Overview
    6.7 Keygen
        6.7.2 Chickenpox Vaccine Product Category, Application and Specification
            6.7.2.1 Product A
            6.7.2.2 Product B
        6.7.3 Keygen Chickenpox Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
        6.7.4 Main Business/Business Overview
    6.8 Green Cross
        6.8.2 Chickenpox Vaccine Product Category, Application and Specification
            6.8.2.1 Product A
            6.8.2.2 Product B
        6.8.3 Green Cross Chickenpox Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
        6.8.4 Main Business/Business Overview
    6.9 Biken
        6.9.2 Chickenpox Vaccine Product Category, Application and Specification
            6.9.2.1 Product A
            6.9.2.2 Product B
        6.9.3 Biken Chickenpox Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
        6.9.4 Main Business/Business Overview

7 Chickenpox Vaccine Manufacturing Cost Analysis
    7.1 Chickenpox Vaccine Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Chickenpox Vaccine

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Chickenpox Vaccine Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Chickenpox Vaccine Major Manufacturers in 2016
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 United States Chickenpox Vaccine Market Size (Value and Volume) Forecast (2017-2022)
    11.1 United States Chickenpox Vaccine Sales Volume, Revenue Forecast (2017-2022)
    11.2 United States Chickenpox Vaccine Sales Volume Forecast by Type (2017-2022)
    11.3 United States Chickenpox Vaccine Sales Volume Forecast by Application (2017-2022)
    11.4 United States Chickenpox Vaccine Sales Volume Forecast by Region (2017-2022)

12 Research Findings and Conclusion

13 Appendix
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer